59 related articles for article (PubMed ID: 8796144)
1. Deletion analysis of the p16 tumour suppressor gene in phaeochromocytomas.
Aguiar RC; Dahia PL; Sill H; Toledo SP; Goldman JM; Cross NC
Clin Endocrinol (Oxf); 1996 Jul; 45(1):93-6. PubMed ID: 8796144
[TBL] [Abstract][Full Text] [Related]
2. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
4. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
5. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population.
Biden K; Young J; Buttenshaw R; Searle J; Cooksley G; Xu DB; Leggett B
Hepatology; 1997 Mar; 25(3):593-7. PubMed ID: 9049204
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
7. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
8. p16 (CDKN2/MTS1) gene deletions are rare in prostatic carcinomas in the United States and Japan.
Mangold KA; Takahashi H; Brandigi C; Wada T; Wakui S; Furusato M; Boyd J; Chandler FW; Allsbrook WC
J Urol; 1997 Mar; 157(3):1117-20. PubMed ID: 9072554
[TBL] [Abstract][Full Text] [Related]
9. Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas.
Marchetti A; Buttitta F; Pellegrini S; Bertacca G; Chella A; Carnicelli V; Tognoni V; Filardo A; Angeletti CA; Bevilacqua G
J Pathol; 1997 Feb; 181(2):178-82. PubMed ID: 9120722
[TBL] [Abstract][Full Text] [Related]
10. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
11. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
Dahia PL; Toledo SP; Mulligan LM; Maher ER; Grossman AB; Eng C
Cancer Res; 1997 Jan; 57(2):310-3. PubMed ID: 9000574
[TBL] [Abstract][Full Text] [Related]
13. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
[TBL] [Abstract][Full Text] [Related]
14. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
Chaussade L; Eymin B; Brambilla E; Gazzeri S
Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of p16 genetic alterations in head and neck tumours.
Miracca EC; Kowalski LP; Nagai MA
Br J Cancer; 1999 Oct; 81(4):677-83. PubMed ID: 10574255
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
17. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
18. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
Dammann R; Schagdarsurengin U; Seidel C; Trümpler C; Hoang-Vu C; Gimm O; Dralle H; Pfeifer GP; Brauckhoff M
Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):1-7. PubMed ID: 15662588
[TBL] [Abstract][Full Text] [Related]
19. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
20. PTEN gene loss, but not mutation, in benign and malignant phaeochromocytomas.
van Nederveen FH; Perren A; Dannenberg H; Petri BJ; Dinjens WN; Komminoth P; de Krijger RR
J Pathol; 2006 Jun; 209(2):274-80. PubMed ID: 16538614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]